As a medical oncologist with 20+ years of oncology drug development experience, much of Jim’s career has focused on developing ADCs, including as CMO at Immunogen and roles within Pfizer, Bayer and Takeda.

Jim has also served the FDA as a medical oncology review officer and provided independent consultancy and served as interim CMO to numerous biotech companies including Idera, NBE Therapeutics, Fusion, and ZielBio.